| Literature DB >> 35392938 |
Alla Philippova1, Raisa Aringazina2, Gulnara Kurmanalina3, Vladimir Beketov4.
Abstract
BACKGROUND: The present study aims to determine the structure of morbidity in workers contacting industrial aerosols, assess the timeliness of diagnosing dust-induced lung disease in major industrial centers, and optimize diagnostics for early detection of occupational lung diseases in workers exposed to industrial dust hazards.Entities:
Keywords: Chronic obstructive pulmonary disease; Dust lung diseases; Epidemiology; Occupational chronic bronchitis; Occupational diseases; Pneumoconiosis
Year: 2022 PMID: 35392938 PMCID: PMC8991489 DOI: 10.1186/s12982-022-00111-0
Source DB: PubMed Journal: Emerg Themes Epidemiol ISSN: 1742-7622
Nosological features of patients by sex, age, and duration of service under hazardous working conditions
| Nosological groups | Number of people | Males | Females | Average age | Average work experience | |
|---|---|---|---|---|---|---|
| 1 | PC | 52 | 43 | 9 | 55.4 ± 6.24 | 20.3 ± 7.45 |
| 2 | COB | 36 | 27 | 9 | 56.4 ± 6.65 | 22.4 ± 6.47 |
| 3 | COPD | 26 | 15 | 11 | 57.1 ± 6.57 | 22.6 ± 6.27 |
PC, Pneumoconiosis; COB, chronic occupational bronchitis; COPD, chronic obstructive pulmonary disease
Fig. 1Structure of newly detected occupational diseases resulting from exposure to industrial aerosols for 2016–2020
Occupational pathology due to exposure to industrial aerosols according to the Centre for Occupational Pathology in 2016–2020
| Seq. No. | Nosology | Number of patients detected in different years | |||||
|---|---|---|---|---|---|---|---|
| 2016 | 2017 | 2018 | 2019 | 2020 | Total | ||
| 1 | Chronic bronchitis | 44 | 37 | 48 | 32 | 41 | 202 |
| 2 | Pneumoconiosis | 12 | 14 | 8 | 11 | 14 | 59 |
| 3 | Silicosis | 6 | 4 | 5 | 5 | 7 | 27 |
| 4 | Silicotuberculosis | 1 | 0 | 0 | 1 | 1 | 3 |
| 5 | COPD | 12 | 9 | 8 | 13 | 11 | 53 |
| Total | 75 | 64 | 69 | 62 | 74 | 344 | |
Fig. 2Distribution of patients with newly diagnosed occupantional diseases caused by exposure to industrial aerosols in 2016–2020 by age group (A) and work experience with dust hazards (B)
Fig. 3Distribution of patients with newly diagnosed occupational diseases caused by exposure to industrial aerosols by occupation in 2016–2020
Detectability of clinical signs
| Symptoms | PC and silicosis | Dust-induced CB | COPD | p 1–2 | p 1–3 | p 2–3 |
|---|---|---|---|---|---|---|
| Dyspnea at rest | 0 (0%) | 4 (11.1%) | 9 (34.6%) | 0.342 | 0.001 | 0.026 |
| Dyspnea at excersing | 33 (64.5%) | 26 (72.2%) | 17 (65.4%) | 0.711 | 0.865 | 0.743 |
| Dry cough | 21 (40.4%) | 21 (58.3%) | 16 (61.5%) | 0.121 | 0.012 | 0.314 |
| Cough with sputum | 19 (36.5%) | 6 (16.7%) | 6 (23.1%) | 0.066 | 0.740 | 0.332 |
| Chest pain | 9 (17.3%) | 2 (5.6%) | 6 (23.1%) | 0.223 | 0.436 | 0.015 |
| Increased fatigue | 49 (94.2%) | 33 (91.7%) | 18 (69.2%) | 0.567 | 0.001 | 0.002 |
| Rhinopharyngolaryngitis | 13 (23.5%) | 22 (61.1%) | 7 (26.9%) | 0.001 | 0.564 | 0.023 |
| Box-tone | 18 (34.6%) | 20 (55.6%) | 9 (34.6%) | 0.057 | 0.864 | 0.237 |
| Attenuated breathing | 4 (7.7%) | 5 (13.9%) | 2 (7.7%) | 0.657 | 0.765 | 0.675 |
| Harsh breathing | 24 (46.2%) | 32 (88.9%) | 16 (61.5%) | 0.001 | 0.387 | 0.002 |
| Stertor on forced exhalation | 27 (51.9%) | 28 (77.8%) | 21 (80.8%) | 0.013 | 0.067 | 0.865 |
p ≤ 0.05—differences are statistically significant; p > 0.1—differences are not statistically significant; 0.1 > p > 0.05—differences are found at the level of the statistical trend
PC, Pneumoconiosis; COB, chronic occupational bronchitis; COPD, chronic obstructive pulmonary disease
Indicators of external respiration function (average values) and changes in the volume flow rate in patients (% of the norm)
| Nosological groups | FVC, % | FEV1, % | FEV1/FVC, % | MEF25% | PEFR, % | |
|---|---|---|---|---|---|---|
| 1 | PC (n = 52) | 87.4 ± 7.6 | 86.7 ± 8.8 | 94.7 ± 9.6 | 78.4 ± 7.1 | 73.8 ± .4 |
| 2 | COB (n = 36) | 77.5 ± 8.3 | 77.8 ± 8.7 | 82.6 ± 8.2 | 62.7 ± 7.7 | 66.3 ± 6.8 |
| 3 | COPD (n = 26) | 62.8 ± 6.4 | 61.3 ± 6.1 | 58.3 ± 10.6 | 51.4 ± 8.3 | 48.4 ± 7.3 |
Significance of intergroup differences p 1–2, p 1–3, p 2–3—p < 0.05
PC, Pneumoconiosis; COB, chronic occupational bronchitis; COPD, chronic obstructive pulmonary disease. FVC, forced vital capacity; FEV1, forced expiratory volume 1-s; FEV1/FVC, Tiffeneau-Pinelli index; MEF 25%, maximum expiratory flow rate at 25% of vital capacity; PEFR, peak expiratory flow rate
Degree of respiratory failure in examined patients
| Nosological groups | RF 0 | RF I | RF II | |
|---|---|---|---|---|
| 1 | PC (n = 52) | 5 (9.6%) | 31 (59.6%) | 16 (30.8%) |
| 2 | COB (n = 36) | 8 (22.2%) | 23 (63.9%) | 5 (13.9%) |
| 3 | COPD (n = 26) | 3 (11.5%) | 15 (57.7%) | 8 (30.8%) |
PC, pneumoconiosis; COB, chronic occupational bronchitis; COPD, chronic obstructive pulmonary disease; RF, respiratory failure
Fig. 4Echocardiographic signs of cor pulmonale in the examined patients (%). PC, pneumoconiosis; COB, chronic occupational bronchitis; COPD, chronic obstructive pulmonary disease
Fig. 5Distribution of patients with chronic cor pulmonale by circulatory failure stage (%). PC, pneumoconiosis; COB, chronic occupational bronchitis; COPD, chronic obstructive pulmonary disease